NCT07002125 Whole Body Vibration Therapy in Individuals With Type 2 Diabetes
| NCT ID | NCT07002125 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Medipol University |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-08-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this interventional study is to investigate the effect of whole body vibration therapy on muscle oxygenation, vibration sensation, functional capacity and balance in individuals with Type 2 diabetes. The main questions aimed to be answered are: * Does whole body vibration therapy affect peripheral muscle oxygenation? * Does whole body vibration therapy improve vibration sense, functional capacity and balance compared to aerobic exercise? Participants' muscle oxygenation, vibration sensation, functional capacity and balance parameters will be assessed. They will participate in a whole body vibration therapy or aerobic training program.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the research * Being diagnosed with type 2 diabetes * 18 years of age or older * HbA1c level to be 6.5-10% * Having a clinical history of diabetes between 2-10 years * Receiving oral hypoglycemic agent treatment * At least three HbA1c measurements within 12 to 24 months * Hemoglobin variability score (HVS) \<50 * Being able to walk independently * Mini mental test score ≥ 24 * Vastus lateralis muscle adipose tissue thickness \<20mm * BMI \<30 kg/m2 Exclusion Criteria: * Previous or concurrent psychiatric, neurological, orthopedic or systemic illness * Use of insulin in treatment * Diabetic neuropathy * Foot ulcer * Participation in any exercise program in the last 6 months * History of major hypoglycemia in the last 12 months * Working or have worked in a job with high exposure to mechanical whole body vibrations * Conditions that may contraindicate whole body vibration (deep vein thrombosis, severe osteoporosis, active cancer, implanted medical devices, etc.) * Hearing, vision and perception problems that may affect research results
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07002125 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07002125 currently recruiting?
Yes, NCT07002125 is actively recruiting participants. Contact the research team at selcansuicmez@hotmail.com for enrollment information.
Where is the NCT07002125 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07002125 clinical trial?
NCT07002125 is sponsored by Ankara Medipol University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.